October 18, 2017
Dr. Peter Schlegel, Chairman of Urology at Weill Cornell Medicine, was featured in Newsweek, discussing the potential for a male birth control pill that would temporarily stop sperm production. Dr. Schlegel comments on recent research that lays a "genetic foundation for male birth control" in an animal study. He also explains some of the biological barriers that make the development of a male birth control pill a complex task:
You can read the full article on Newsweek here.
For additional educational resources on male reproductive and sexual medicine, please visit our clinical conditions webpages here:
